Dietary n-3 PUFA May Attenuate Experimental Colitis

Area of Science:

• Gastroenterology
• Nutritional Science
• Immunology

Background:

• Inflammatory bowel diseases (IBD) involve genetic and environmental factors, with diet being a suspected contributor.
• While n-3 polyunsaturated fatty acids (PUFA) show promise in animal models, human trials have yielded mixed results.
• The study investigates the hypothesis that the timing and pattern of dietary fatty acid intake influence intestinal inflammation.

Purpose of the Study:

• To evaluate the impact of dietary PUFA composition on the development of intestinal inflammation.
• To explore the role of dietary fatty acid patterns in modulating the intestinal environment and inflammation genesis.

Main Methods:

• Rodents were fed diets with varying PUFA compositions for four weeks prior to inducing colitis via TNBS.
• Colon inflammatory markers, gut barrier function, and inflammatory pathway gene expression were assessed.
• Quantitative PCR arrays were used to determine inflammatory pathway activity.

Main Results:

• The n-3 PUFA diet significantly reduced colon expression of iNOS and COX-2, and decreased IL-6 and LTB4 production.
• A trend towards decreased TNF-α production was observed in the n-3 PUFA group (P = 0.0617).
• The n-9 PUFA diet also led to a reduction in colon IL-6 production (P < 0.05).

Conclusions:

• Dietary n-3 PUFA can attenuate inflammatory markers, influencing colitis development.
• Gut barrier function and specific gene expressions related to mucus and tight junctions were not significantly altered by the diets.
• Further research is needed to establish scientifically-backed dietary guidelines for IBD management.